Shares of Pharmacyclics (PCYC +9%) jump higher today after Wedbush adds it to its "Best Ideas"...

|By:, SA News Editor

Shares of Pharmacyclics (PCYC +9%) jump higher today after Wedbush adds it to its "Best Ideas" list and raises its price target from $17 to $25. Wedbush says the stock should outperform over the next 12 months as the company rolls out its new drug, PCI-32765.